Skeletal myoblasts for cardiac repair

Shazia Durrani, Mikhail Konoplyannikov, Muhammad Ashraf, Khawaja Husnain Haider

Research output: Contribution to journalReview article

38 Citations (Scopus)

Abstract

Stem cells provide an alternative curative intervention for the infarcted heart by compensating for the cardiomyocyte loss subsequent to myocardial injury. The presence of resident stem and progenitor cell populations in the heart, and nuclear reprogramming of somatic cells with genetic induction of pluripotency markers are the emerging new developments in stem cell-based regenerative medicine. However, until safety and feasibility of these cells are established by extensive experimentation in in vitro and in vivo experimental models, skeletal muscle-derived myoblasts, and bone marrow cells remain the most well-studied donor cell types for myocardial regeneration and repair. This article provides a critical review of skeletal myoblasts as donor cells for transplantation in the light of published experimental and clinical data, and indepth discussion of the advantages and disadvantages of skeletal myoblast-based therapeutic intervention for augmentation of myocardial function in the infarcted heart. Furthermore, strategies to overcome the problems of arrhythmogenicity and failure of the transplanted skeletal myoblasts to integrate with the host cardiomyocytes are discussed.

Original languageEnglish (US)
Pages (from-to)919-932
Number of pages14
JournalRegenerative Medicine
Volume5
Issue number6
DOIs
StatePublished - Nov 1 2010
Externally publishedYes

Fingerprint

Skeletal Myoblasts
Repair
Stem Cells
Stem cells
Cells
Cardiac Myocytes
Regenerative Medicine
Muscle
Myoblasts
Cell Transplantation
Bone
Bone Marrow Cells
Transcriptional Activation
Regeneration
Skeletal Muscle
Theoretical Models
Safety
Wounds and Injuries
Population

Keywords

  • heart
  • myoblast
  • myocardium
  • stem cell

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

Durrani, S., Konoplyannikov, M., Ashraf, M., & Haider, K. H. (2010). Skeletal myoblasts for cardiac repair. Regenerative Medicine, 5(6), 919-932. https://doi.org/10.2217/rme.10.65

Skeletal myoblasts for cardiac repair. / Durrani, Shazia; Konoplyannikov, Mikhail; Ashraf, Muhammad; Haider, Khawaja Husnain.

In: Regenerative Medicine, Vol. 5, No. 6, 01.11.2010, p. 919-932.

Research output: Contribution to journalReview article

Durrani, S, Konoplyannikov, M, Ashraf, M & Haider, KH 2010, 'Skeletal myoblasts for cardiac repair', Regenerative Medicine, vol. 5, no. 6, pp. 919-932. https://doi.org/10.2217/rme.10.65
Durrani S, Konoplyannikov M, Ashraf M, Haider KH. Skeletal myoblasts for cardiac repair. Regenerative Medicine. 2010 Nov 1;5(6):919-932. https://doi.org/10.2217/rme.10.65
Durrani, Shazia ; Konoplyannikov, Mikhail ; Ashraf, Muhammad ; Haider, Khawaja Husnain. / Skeletal myoblasts for cardiac repair. In: Regenerative Medicine. 2010 ; Vol. 5, No. 6. pp. 919-932.
@article{177d49138b4f4aa39f1038c1b9e46a02,
title = "Skeletal myoblasts for cardiac repair",
abstract = "Stem cells provide an alternative curative intervention for the infarcted heart by compensating for the cardiomyocyte loss subsequent to myocardial injury. The presence of resident stem and progenitor cell populations in the heart, and nuclear reprogramming of somatic cells with genetic induction of pluripotency markers are the emerging new developments in stem cell-based regenerative medicine. However, until safety and feasibility of these cells are established by extensive experimentation in in vitro and in vivo experimental models, skeletal muscle-derived myoblasts, and bone marrow cells remain the most well-studied donor cell types for myocardial regeneration and repair. This article provides a critical review of skeletal myoblasts as donor cells for transplantation in the light of published experimental and clinical data, and indepth discussion of the advantages and disadvantages of skeletal myoblast-based therapeutic intervention for augmentation of myocardial function in the infarcted heart. Furthermore, strategies to overcome the problems of arrhythmogenicity and failure of the transplanted skeletal myoblasts to integrate with the host cardiomyocytes are discussed.",
keywords = "heart, myoblast, myocardium, stem cell",
author = "Shazia Durrani and Mikhail Konoplyannikov and Muhammad Ashraf and Haider, {Khawaja Husnain}",
year = "2010",
month = "11",
day = "1",
doi = "10.2217/rme.10.65",
language = "English (US)",
volume = "5",
pages = "919--932",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Skeletal myoblasts for cardiac repair

AU - Durrani, Shazia

AU - Konoplyannikov, Mikhail

AU - Ashraf, Muhammad

AU - Haider, Khawaja Husnain

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Stem cells provide an alternative curative intervention for the infarcted heart by compensating for the cardiomyocyte loss subsequent to myocardial injury. The presence of resident stem and progenitor cell populations in the heart, and nuclear reprogramming of somatic cells with genetic induction of pluripotency markers are the emerging new developments in stem cell-based regenerative medicine. However, until safety and feasibility of these cells are established by extensive experimentation in in vitro and in vivo experimental models, skeletal muscle-derived myoblasts, and bone marrow cells remain the most well-studied donor cell types for myocardial regeneration and repair. This article provides a critical review of skeletal myoblasts as donor cells for transplantation in the light of published experimental and clinical data, and indepth discussion of the advantages and disadvantages of skeletal myoblast-based therapeutic intervention for augmentation of myocardial function in the infarcted heart. Furthermore, strategies to overcome the problems of arrhythmogenicity and failure of the transplanted skeletal myoblasts to integrate with the host cardiomyocytes are discussed.

AB - Stem cells provide an alternative curative intervention for the infarcted heart by compensating for the cardiomyocyte loss subsequent to myocardial injury. The presence of resident stem and progenitor cell populations in the heart, and nuclear reprogramming of somatic cells with genetic induction of pluripotency markers are the emerging new developments in stem cell-based regenerative medicine. However, until safety and feasibility of these cells are established by extensive experimentation in in vitro and in vivo experimental models, skeletal muscle-derived myoblasts, and bone marrow cells remain the most well-studied donor cell types for myocardial regeneration and repair. This article provides a critical review of skeletal myoblasts as donor cells for transplantation in the light of published experimental and clinical data, and indepth discussion of the advantages and disadvantages of skeletal myoblast-based therapeutic intervention for augmentation of myocardial function in the infarcted heart. Furthermore, strategies to overcome the problems of arrhythmogenicity and failure of the transplanted skeletal myoblasts to integrate with the host cardiomyocytes are discussed.

KW - heart

KW - myoblast

KW - myocardium

KW - stem cell

UR - http://www.scopus.com/inward/record.url?scp=78649360438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649360438&partnerID=8YFLogxK

U2 - 10.2217/rme.10.65

DO - 10.2217/rme.10.65

M3 - Review article

C2 - 21082891

AN - SCOPUS:78649360438

VL - 5

SP - 919

EP - 932

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 6

ER -